Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
JNCI Cancer Spectrum
|
July 31, 2019
Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers
Shawn Yost, Elise Ruark, Ludmil B Alexandrov, et al.
Wellcome Open Research
|
September 4, 2018
The ICR639 CPG NGS validation series: A resource to assess analytical sensitivity of cancer predisposition gene testing
Shazia Mahamdallie, Elise Ruark, Esty Holt, et al.
Scientific Reports
|
August 4, 2016
OpEx - a validated, automated pipeline optimised for clinical exome sequence analysis
Elise Ruark, Márton Münz, Matthew Clarke, et al.
Wellcome Open Research
|
December 4, 2018
ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series
Elise Ruark, Esty Holt, Anthony Renwick, et al.
Wellcome Open Research
|
June 9, 2018
CoverView: a sequence quality evaluation tool for next generation sequencing data
Márton Münz, Shazia Mahamdallie, Shawn Yost, et al.
Wellcome Open Research
|
July 12, 2018
The Quality Sequencing Minimum (QSM): providing comprehensive, consistent, transparent next generation sequencing data quality assurance
Shazia Mahamdallie, Elise Ruark, Shawn Yost, et al.
F1000Research
|
September 26, 2018
The ICR142 NGS validation series: a resource for orthogonal assessment of NGS analysis
Elise Ruark, Anthony Renwick, Matthew Clarke, et al.
Genome Medicine
|
August 29, 2015
CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting
Márton Münz, Elise Ruark, Anthony Renwick, et al.
Wellcome Open Research
|
May 2, 2017
Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN
Anna Fowler, Shazia Mahamdallie, Elise Ruark, et al.
Wellcome Open Research
|
June 21, 2017
The ICR96 exon CNV validation series: a resource for orthogonal assessment of exon CNV calling in NGS data
Shazia Mahamdallie, Elise Ruark, Shawn Yost, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
JNCI Cancer Spectrum
|
July 31, 2019
Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers
Shawn Yost, Elise Ruark, Ludmil B Alexandrov, et al.
Wellcome Open Research
|
September 4, 2018
The ICR639 CPG NGS validation series: A resource to assess analytical sensitivity of cancer predisposition gene testing
Shazia Mahamdallie, Elise Ruark, Esty Holt, et al.
Scientific Reports
|
August 4, 2016
OpEx - a validated, automated pipeline optimised for clinical exome sequence analysis
Elise Ruark, Márton Münz, Matthew Clarke, et al.
Wellcome Open Research
|
December 4, 2018
ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series
Elise Ruark, Esty Holt, Anthony Renwick, et al.
Wellcome Open Research
|
June 9, 2018
CoverView: a sequence quality evaluation tool for next generation sequencing data
Márton Münz, Shazia Mahamdallie, Shawn Yost, et al.
Wellcome Open Research
|
July 12, 2018
The Quality Sequencing Minimum (QSM): providing comprehensive, consistent, transparent next generation sequencing data quality assurance
Shazia Mahamdallie, Elise Ruark, Shawn Yost, et al.
F1000Research
|
September 26, 2018
The ICR142 NGS validation series: a resource for orthogonal assessment of NGS analysis
Elise Ruark, Anthony Renwick, Matthew Clarke, et al.
Genome Medicine
|
August 29, 2015
CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting
Márton Münz, Elise Ruark, Anthony Renwick, et al.
Wellcome Open Research
|
May 2, 2017
Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN
Anna Fowler, Shazia Mahamdallie, Elise Ruark, et al.
Wellcome Open Research
|
June 21, 2017
The ICR96 exon CNV validation series: a resource for orthogonal assessment of exon CNV calling in NGS data
Shazia Mahamdallie, Elise Ruark, Shawn Yost, et al.
Page
of 3